Tuesday, June 30th 2020
The French research national agency (ANR) has granted Vaxinano funding to develop an innovative vaccine against Covid-19.
...Read more
Thursday, April 16th 2020
Nasal vaccination with Vaxinano's nanoparticles against flu virus inhibits virus transmission
...Read more
Wednesday, February 12th 2020
Didier Betbeder, CEO & CSO of Vaxinano, explains how innovative and efficient is its vaccine platform.
...Read more
Thursday, January 16th 2020
Didier Betbeder, CEO & CSO of Vaxinano, presents the vaccine platform to Vaccinology Club of the French Society for Immunology
...Read more
Thursday, December 05th 2019
Didier Betbeder, CEO & CSO of Vaxinano, presents for the first time the preclinical results of the anti-toxoplasma vaccine, including non-human primates.
...Read more
Monday, July 01st 2019
Vaxinano Announces the Signing of a Third Research and Development Program with a Leader in the Vaccine Industry.
...Read more
Thursday, June 06th 2019
Faced with the worldwide emergence of antibiotic resistance, Vaxinano obtains funding for research with Immunova Analises Biologicas and Lesaffre International to develop a vaccine against avian colibacillosis.
...Read more
27/03/2019
Visit the website
Wednesday, January 16th 2019
A new pharmaceutical industrial leader trusts Vaxinano for the development of veterinary vaccines.
...Read more
Tuesday, December 11st 2018
This December 11 was held the award ceremony of the 2018 Innovation competition where Vaxinano was rewarded in the field of Health.
...Read more